Siren »

Fulcrum Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Siren from 13F filings

Historical chart of Siren investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 2.0M 11.31

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Olema Pharmaceuticals (OLMA)
Disc Medicine (IRON)
Structure Therapeutics Sponsored Ads (GPCR)
Tango Therapeutics (TNGX)
Arcus Biosciences Incorporated (RCUS)
Stoke Therapeutics (STOK)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Siren

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Point72 Asset Management
Siren
First Turn Management
Balyasny Asset Management
D. E. Shaw & Co
Ikarian Capital
ADAR1 Capital Management

View all funds holding Fulcrum Therapeutics